Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV iron isomaltoside vs oral ferrous fumarate for iron deficiency in pregnancy
2017-000776-29Phase 4Completed
- Sponsor
- Pharmacosmos
- Start
- Feb 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferric derisomaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Pharmacosmos. Started Feb 2017; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2017-000776-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000776-29.